14 Sep 2023
Anavex’s Phase 2b/3 Trial of Blarcames ...
Significant Reduction of Amyloid Beta Biomarkers of Alzheimer’s Pathology NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) — Anav ...
Get access to the latest news, guides, stock and crypto updates, and take your financial portfolio to the next level.